Clinical trials
Phase 3 COVID-19 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 19 |
| 2021 | 14 |
| 2022 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Unknown status | 8 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Promomed, LLC | 6 |
| AstraZeneca | 2 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 2 |
| Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 2 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2 |
| NPO Petrovax | 2 |
| Novartis Pharmaceuticals | 2 |
| R-Pharm | 2 |
| RSV Therapeutics LLC | 2 |
| AO GENERIUM | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 39 |
| Coronavirus Infections | 9 |
| Cytokine Release Syndrome | 3 |
| Pneumonia | 3 |
| Lung Diseases | 2 |
| Acute Lung Injury | 1 |
| Coronaviridae Infections | 1 |
| Disease | 1 |
| Fibrosis | 1 |
| Lung Diseases, Interstitial | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.